Reprint

<em>Babesia</em> and Human Babesiosis

Edited by
June 2022
294 pages
  • ISBN978-3-0365-4472-4 (Hardback)
  • ISBN978-3-0365-4471-7 (PDF)

This book is a reprint of the Special Issue Babesia and Human Babesiosis that was published in

Biology & Life Sciences
Medicine & Pharmacology
Public Health & Healthcare
Summary

Babesiosis, caused by tick-transmitted intraerythrocytic parasites (Babesia spp.), occurs worldwide. The disease mainly affects livestock, but records of infections in humans are increasing, and the disease is considered to be emerging worldwide. This book provides a comprehensive and holistic view of Babesia species that can infect humans. Numerous experts analyze, in detail, basic aspects of the biology of Babesia, the pathology of the babesiosis highlighting the pathogenesis of babesiosis in sickle cell, the eco-epidemiology of tick vectors and the impact of climate change on them, the current status, and future prospects for laboratory diagnosis and measures to prevent transfusion transmission. The book also focused on unidentified Babesia parasites that continue to emerge, most likely from wildlife, for which neither tick vector species nor vertebrate reservoir host species are currently known. Lastly, current and new therapies for infected patients, in vitro and in vivo culture systems for antibabesial evaluation and measures to prevent infections are also considered.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
babesiosis; Babesia microti; Babesia duncani; parasite; therapy; atovaquone; endochin-like quinolones (ELQs); Babesia microti; human babesiosis; Nantucket Island; epidemiology; ecology; human risk; European babesiosis; Babesia divergens; Babesia venatorum; Babesia microti; Ixodes ricinus; parasite identity; epidemiology; clinical cases; diagnosis; treatment; Babesia microti; Babesia; diversity; phylogenetic analysis; Babesia; blood transfusion; prevention; screening; babesiosis; aspartyl protease; plasmepsin; apicomplexa; piroplasmida; Babesia; Babesia microti; BmIPA48; BMR1_03g00960; piroplasmid rhoptry-associated protein-1 (pRAP-1); human babesiosis; ticks; Babesia sp.; biological cycle; experimental transmission; experimental models; Ixodes ricinus; Ixodes scapularis; Babesia microti; Babesia divergens; climate; global warming; Babesia divergens; Babesia sp. MO1; Babesia capreoli; rap-1a; ama-1; phylogeny; Babesia; sickle-cell anemia; hemolysis; haemoglobinopathies; babesiosis; Babesia microti; epidemiology; immunoepidemiology; case surveillance; babesiosis; human babesiosis; Babesia microti; therapeutic drugs; peptidases; Babesia microti; antibody-based assays; nucleic acid tests; multiplex detection; next generation sequencing; glycosylphosphatidylinositol; protein structure; antigen; Babesia; host blood analysis; fallow deer; ixodid ticks; piroplasm; red deer; Theileria; human babesiosis; Babesia bovis; Babesia bigemina; Colombia; n/a; parasite; babesiosis; Babesia duncani; in vitro culture; erythrocytes; DMEM-F12; virulence